Cargando…
Algorithm for pre-emptive glycopeptide treatment in patients with haematologic malignancies and an Enterococcus faecium bloodstream infection
INTRODUCTION: Nowadays Enterococcus faecium has become one of the most emerging and challenging nosocomial pathogens. The aim of this study was to determine risk factors in haematology patients who are at risk of an Enterococcus faecium bloodstream infection (BSI) and should be considered for pre-em...
Autores principales: | Zhou, Xuewei, Arends, Jan P, Span, Lambert FR, Friedrich, Alexander W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3856451/ https://www.ncbi.nlm.nih.gov/pubmed/24025668 http://dx.doi.org/10.1186/2047-2994-2-24 |
Ejemplares similares
-
Algorithm for empirical glycopeptide treatment in patients with hematologic malignancies and enterococcus faecium blood stream infection
por: Zhou, X, et al.
Publicado: (2011) -
Acquisition of Daptomycin Resistance by Enterococcus faecium Confers Collateral Sensitivity to Glycopeptides
por: Zeng, Weiliang, et al.
Publicado: (2022) -
Daptomycin versus Glycopeptides for the Treatment of Enterococcus faecium Bacteraemia: A Cohort Study
por: Echeverría-Esnal, Daniel, et al.
Publicado: (2021) -
First glycopeptide-resistant Enterococcus faecium isolate from blood culture in Ankara, Turkey.
por: Basustaoglu, A, et al.
Publicado: (2001) -
245. Comparing Enterococcus faecalis and Enterococcus faecium Bloodstream Infections’ Severity and Mortality
por: Varghese, Shawn, et al.
Publicado: (2023)